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Purple urine bag syndrome (PUBS) is a unique disease entity characterized by an alarming purple discoloration of the urine
secondary to recurrent urinary tract infections with indigo- and indirubin-producing bacteria. It is usually associated with pro-
longed urinary catheterization and chronic debilitated states. We hereby present a concise review of this rare phenomenon with
historicperspectives,epidemiology,emphasizingoncurrentconceptsofetiology,pathogenesis,relevantclinicalassociations,treat-
ment modalities, prognosis, and future directions in PUBS. In addition, we highlight an interesting occurrence of this intriguing
phenomenon in a 39-year-old gentleman at our institution.
1.Introduction
Purple urine bag syndrome (PUBS) is a rare disease entity
ﬁrst reported in 1978 and is signiﬁed by an alarming purple
discoloration of the urine usually seen in women and chron-
ically debilitated patients with long term indwelling urinary
catheters. Recurrent urinary tract infections with bacteria
containing sulphatase and phosphatase enzymes results in
the formation of pigments; indirubin (red) and indigo
(blue),themixtureofwhichturnstheurinepurple.Wehere-
by present a concise review of this unique phenomenon re-
garding etiology, pathogenesis, clinical associations, progno-
sis, and future directions in PUBS.
2. Epidemiology
Historically PUBS dates back to 1812 when physicians taking
care of King George III noted bluish discoloration in his
urine [1] and the urinary catheter and bag. King George III
alsohad chronic constipation whichis alsoconsidered as one
of the major risk factors leading to PUBS. In the literature
PUBS was ﬁrst reported in 1978 [2]. It is an uncommon
occurrence, but prevalence of PUBS has been reported to be
as high as 9.8% in institutionalized patients with long-term
indwelling urinary catheter use [3].
3. Pathogenesis
The major risk factors implicated in etiology of PUBS are
outlined in Table 1.
The pathogenesis stems from multiple bacterial urinary
tractinfectionsmostcommonlywithProvidenciastuarttiand
rettgeri, Proteus mirabilis, Pseudomonas auruginosa, Klebsiella
pneumoniae,Escherichiacoli,Morganella,andcitrobacter spe-
cies, Enterococci, and Group B Streptococci. This is followed
by a series of biochemical conversion reactions as shown in
Figure 1 starting from deamination of tryptophan to indole,
pyruvic acid and ammonia, conjugation of indole to indoxyl
sulfate (indican), and oxidation of indican to indigo (blue)
and indirubin (red) which combine with the catheter tubing
to give purple appearance.
Whenoxygenisscarce,indoxylisconvertedtoistatinand
thenindirubin. In2008, Chung reported acaseofPUBSwith
acidic urine [6]whichcastsdoubt on theassociation of urine
alkalinity.
4. ClinicalPresentations
The patients are typically elderly nursing home women
with recurring urinary tract infections. Also patients with
chronic debilitation for instance in spinal cord injuries are2 International Journal of Nephrology
Table 1: Risk factors and associated mechanisms in PUBS.
Risk factors for PUBS Associated mechanisms
Female gender Predisposing anatomy to UTI
occurrence
Increased tryptophan dietary
content
Increased available substrate for
conversion
Increased urine alkalinity [4] Facilitates indoxyl oxidation
Severe constipation [5] Increased time for bacterial
deamination
Chronic indwelling urinary
catheterization Increased risk of UTIs
High urinary bacterial load [5] Bacterial sulfatase/phosphatase
availability
Renal failure Impaired clearance of indoxyl
sulfate
Tryptophan
Deamination
Indole
Sulfatase/phosphatase
Indoxyl
Oxidation
Hepatic conjugation Indigo (blue)
Indoxyl sulfate 
Indirubin (red)
(indican)
Figure 1: Biochemical pathway of conversion of tryptophan to
indigo and indirubin.
more prone to development of PUBS. Here we would like
to brieﬂy focus on a case of PUBS at our hospital which
further highlights the clinical spectrum of this phenomenon.
A 39-year-old gentleman was admitted to the hospital
with fever, chills, and sweating since one week before admis-
sion. The patient’s past medical history was signiﬁcant for
a motor vehicle accident in 2001 which led to injury to
the cervical spine with subsequent paraplegia along with
the development of a neurogenic bladder. The neurogenic
bladder had been managed by indwelling suprapubic cath-
eterization since the last eight years. The suprapubic catheter
had been changed two days before admission by his wife
at home. His urine culture grew four diﬀerent organisms,
namely, Providencia rettgeri, Pseudomonas auruginosa, Pro-
teus mirabilis,a n dEnterococcus faecalis. The urine in the bag
as well as the tubing was found to be purple (Figure 2).
Uponfurtherquestioning,itwasrevealedthatthepatient
had the purple urine since the last 1 year. The patient had
a history of recurrent urinary tract infections (UTIs) with
multiple bacteria in the past. Based on these facts he was
Figure 2: Purple discoloration of the urine with similar changes in
the urine bag and tubing.
diagnosed with PUBS and treatment for the UTI was ini-
tiated with intravenous piperacillin tazobactam and cipro-
ﬂoxacin. Finally after initiating the antibiotic treatment and
switching the catheter to a nonteﬂon one, the urinary tract
infection and PUBS gradually resolved over a period of ﬁve
to six days.
There have been occurrences of PUBS in patients with
chronic renal failure who are hemodialysis dependent [7]a s
well as in patients with nephrostomy tubes. A recent case
report in 2010 showed an occurrence of PUBS in a patient
with an ileal conduit and urinary diversion [8]. Another
association which exists is the more frequent occurrence of
PUBS with polyvinylchloride (PVC) containing urine bags
as compared to non-PVC urine bags [9]. Cooccurrence with
intussusceptionhasalsobeendescribed,butevidenceofclear
cut association is still lacking [10].
5. Treatment
TreatmentisdirectedattheunderlyingUTIaswellascontrol
of constipation and good urologic sanitation. Good care of
the urinary catheters will prevent UTIs and hence this phe-
nomenon as well. Though described as relatively benign,
review of the literature reveals couple of cases of PUBS
whichprogressedtoFournier’sgangrenerequiringaggressive
debridement[11].ThetypicalorganismswhichleadtoPUBS
wereisolatedfromthescrotalwoundcultures.So,totreatthe
patient with PUBS aggressively with antibiotics is a point of
d e b a t ea n dn e e d st ob ef u r t h e ri n v e s t i g a t e d .
6.Prognosis
PUBS is generally a benign process. Despite this fact, it is dis-
tressing for family, friends, and healthcare workers who are
unaware of this phenomenon and tend to become unusuallyInternational Journal of Nephrology 3
alarmed because of the sudden inexplicable discoloration of
the urine and sometimes the urine bag. Nevertheless, physi-
cians should be aware of the fact that this syndrome signals
underlying recurrent UTIs, due to improper care of the
urinary catheters and improper sanitation. PUBS is also as-
sociated generally with higher incidence of morbidity and
mortality than urinary tract infections alone without this
occurrence [12].
7. Conclusion
Though commonly benign, there have been case reports in
the literature of PUBS progressing to Fournier’s gangrene
and doubts on associations of increased urine alkalinity and
PVC containing urinary bags. Further deﬁnitive studies are
required to elucidate clear-cut pathogenesis, morbidity, and
mortality implications and to delineate standard guidelines
to treat this unique phenomenon.
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